Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer

[91] Charette LA(1997)p53 protein expression as prognostic factor in human pancreatic cancer Anticancer Res 17 2779-2245

[92] Salem RR(1997)Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas Cancer Res 57 3126-76

[93] Camp RL(2000)High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma Cancer 88 2239-2022

[94] Rimm DL(1998)Ki-ras and p53 gene mutations in pancreatic ductal carcinoma: a relationship with tumor phenotype and survival Eur J Histochem 42 67-45

[95] Burtness BA(1996)bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome Clin Cancer Res 2 2015-449

[96] Ciardello F(2007)Long-term survival after radical resection for pancreatic head and ampullary cancer: a potential role for the EGF-R Dig Surg 24 38-308

[97] Tortora G(2002)Angiogenesis as a prognostic indicator in pancreatic ductal adenocarcinoma Anticancer Res 22 445-2955

[98] Coppola D(2002)Expression of the bcl-2 gene and its significance in human pancreatic carcinoma Hepatobiliary Pancreat Dis Int 1 306-4121

[99] Lu L(2009)Associations between selected biomarkers and prognosis in a population-based pancreatic cancer tissue microarray Cancer Res 69 2950-292

[100] Fruehauf JP(2001)The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma Clin Cancer Res 7 4115-286

[91] Charette LA(1997)p53 protein expression as prognostic factor in human pancreatic cancer Anticancer Res 17 2779-2245

[92] Salem RR(1997)Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas Cancer Res 57 3126-76

[93] Camp RL(2000)High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma Cancer 88 2239-2022

[94] Rimm DL(1998)Ki-ras and p53 gene mutations in pancreatic ductal carcinoma: a relationship with tumor phenotype and survival Eur J Histochem 42 67-45

[95] Burtness BA(1996)bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome Clin Cancer Res 2 2015-449

[96] Ciardello F(2007)Long-term survival after radical resection for pancreatic head and ampullary cancer: a potential role for the EGF-R Dig Surg 24 38-308

[97] Tortora G(2002)Angiogenesis as a prognostic indicator in pancreatic ductal adenocarcinoma Anticancer Res 22 445-2955

[98] Coppola D(2002)Expression of the bcl-2 gene and its significance in human pancreatic carcinoma Hepatobiliary Pancreat Dis Int 1 306-4121

[99] Lu L(2009)Associations between selected biomarkers and prognosis in a population-based pancreatic cancer tissue microarray Cancer Res 69 2950-292

[100] Fruehauf JP(2001)The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma Clin Cancer Res 7 4115-286